Early diagnosis makes differences

Psoriasis Arthritis (PsA) is an inflammatory disease associated with psoriatic skin disease, which affects 1 upto 3 percent of the population in Europe. Only 30 percent of patients were diagnosed within six months of the onset of symptoms. An early diagnosis reduces risk of permanent joint damages and increase successfully response of therapy. Nevertheless, due to various manifestations of disease, it is often not easy to diagnose PsA. There is still an huge need of research in PsA to increase early diagnosis and reduce the suffering of patients.

To fill this gap and foster research in psoriatic arthritis, five European research institutions have come together to launch the PARTNER Psoriatic Arthritis Network Fellowship Program with the aim of gaining a better understanding of the specific molecular processes and clinical features of the disease.

Prof. Maria Antonietta D´Agostino
Université Paris Quest-Versailles Saint Quentin en Yvelines
Hôpital Ambroise Paré
Hôpitaux Universitaires Paris Ile-de-France Ouest